Abiopharma

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

New Form 4 - Immuneering Corp Filed: 2025-06-24 AccNo: 0001790340-25-000087 Size: 6 KB

New Form 424B3 - iBio, Inc. Filed: 2025-06-24 AccNo: 0001104659-25-061959 Size: 164 KB

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy

Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy

New Form 4 - Immuneering Corp Filed: 2025-06-24 AccNo: 0001790340-25-000085 Size: 4 KB

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference

Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference

Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings

Journey Medical to Join Russell2000® and Russell 3000® Indexes

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome

New Form 6-K - Sanofi Filed: 2025-06-24 AccNo: 0001193125-25-145347 Size: 155 KB

Tivic Health Announces 2025 Annual Meeting of Stockholders

Press Release: DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

New Form 8-K - Journey Medical Corp Filed: 2025-06-24 AccNo: 0001104659-25-061956 Size: 223 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits